In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Hein Heidbuchel
Speaker
Hein Heidbuchel

Manager (Head of department/Section/Senior Researcher/Dean/Director or other), University of Antwerp, Edegem (Belgium)

Specialities : Arrhythmias-General , e-Cardiology, Training and Education

Professor Heidbuchel graduated as MD in 1986 and obtained a PhD in Physiology in 1992. He worked as Research Fellow of the NIH and Fogarty International at the University of Oklahoma (1993–1994) and was Fundamental Clinical Investigator of the Fund for Scientific Research Flanders from 1996 till 2006. He started as Professor of Cardiology – Arrhythmology at the University of Leuven, Belgium in 1994. In October 2016, he became the Chair of Cardiology at Antwerp University. He is President of the European Heart Rhythm Association (EHRA) for a 2018-2020 term. He has published over 275 papers in international peer-reviewed journals.

50 presentations from this speaker

Changes to the EHRA Constitution.

Congress : EHRA 2019

  • Session : EHRA General Assembly
  • Speaker : H Heidbuchel (Antwerp,BE)

Discussion

Congress : EuroPrevent 2019

  • Session : ECG challenges in athletes
  • Speaker : H Heidbuchel (Antwerp,BE)

EuroEco (European health economic trial on home monitoring in ICD and CRT-D patients): a provider perspective on follow-up costs of remote monitoring - results for the CRT-D arm

Congress : EHRA 2019

  • Session : Moderated ePosters 13: mobile and remote technologies: opportunities and challenges
  • Speaker : H Heidbuchel (Antwerp,BE)

Main themes for the current Board.

Congress : EHRA 2019

  • Session : EHRA General Assembly
  • Speaker : H Heidbuchel (Antwerp,BE)

The Apple Heart Study - Discussant Review.

Congress : EHRA 2019

  • Session : Meet the trialist The Apple Heart Study
  • Speaker : H Heidbuchel (Antwerp,BE)

Welcome address.

Congress : EHRA 2019

  • Session : EHRA General Assembly
  • Speaker : H Heidbuchel (Antwerp,BE)

Better use of scientific evidence in clinical practice.

Congress : ESC Congress 2018

  • Session : Advances in anticoagulation to improve patient care in atrial fibrillation
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Conclusions and closing remarks -What is new in implantable cardiac devices?

Congress : ESC Congress 2018

  • Session : What is new in implantable cardiac devices?
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Medtronic

Evolution in atrial fibrillation patient care for stroke prevention.

Congress : ESC Congress 2018

  • Session : Advances in anticoagulation to improve patient care in atrial fibrillation
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Management of sudden death during sports

Congress : EHRA 2018

  • Session : Sudden death during sports: reasons, prevention and management
  • Speaker : H Heidbuchel (Antwerp,BE)

Patient education: practical approach.

Congress : EHRA 2018

  • Session : Leading the way in anticoagulation care in Atrial Fibrillation (AF) patients
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by BMS Pfizer

Questions & Answers - Leading the way in anticoagulation care in AF patients.

Congress : EHRA 2018

  • Session : Leading the way in anticoagulation care in Atrial Fibrillation (AF) patients
  • Speaker : J Camm (London,GB), G Lip (Liverpool,GB), H Heidbuchel (Antwerp,BE), SH Hohnloser (Frankfurt,DE)
  • Sponsored by BMS Pfizer

The "Top Ten" frequently overlooked findings in electrocardiography.

Congress : ESC Congress 2018

  • Session : The "Top Ten" Diagnostic Pitfalls
  • Speaker : H Heidbuchel (Antwerp,BE)

The EHRA Practical Guide: rationale, history, and experience 2013 - 2017

Congress : EHRA 2018

  • Session : The 2018 EHRA Practical Guide for the use of NOACs in patients with atrial fibrillation
  • Speaker : H Heidbuchel (Antwerp,BE)

The evolving role of NOACs in AF patient care - Q&A.

Congress : ESC Congress 2018

  • Session : Advances in anticoagulation to improve patient care in atrial fibrillation
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Athlete with asymptomatic ventricular arrhythmias.

Congress : EHRA 2017

  • Session : The asymptomatic athlete with abnormal EGC: all sports forbidden?
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Joint Session with the European Association of Preventive Cardiology (EAPC)

EHRA activities' report.

Congress : EHRA 2017

  • Session : EHRA General Assembly
  • Speaker : H Heidbuchel (Antwerp,BE)

Endocardial left atrial appaendage occlusion is not as effective as warfarin to prevent ischemic stroke.

Congress : EHRA 2017

  • Session : Left atrial appendage occlusion: state of the art 2017
  • Speaker : H Heidbuchel (Antwerp,BE)

Improving patient care with NOACs: where are we now?

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Left atrial appendage occlusion - Chairperson conclusion

Congress : ESC Congress 2017

  • Session : Left atrial appendage occlusion
  • Speaker : H Heidbuchel (Antwerp,BE)

NOACs and pulmonary vein ablation: evidence and optimal management.

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Panel discussion - Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF.

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

State of the Art: sudden cardiac death in the young

Congress : ESC Congress 2017

  • Session : Sudden cardiac death in the young
  • Speaker : H Heidbuchel (Antwerp,BE)

A case of persistent atrial fibrillation - What do the Guidelines say?

Congress : ESC Congress 2016

  • Session : New ESC Guidelines: when, what and how?
  • Speaker : H Heidbuchel (Antwerp,BE)

A routine yearly sports medical evaluation of an elite cyclist. Or not?

Congress : ESC Congress 2016

  • Session : Evaluating athletes for cardiovascular disease - Challenging cases explained by the experts
  • Speaker : H Heidbuchel (Antwerp,BE)

Heart team panel live on stage discussion

Congress : ESC Congress 2016

  • Session : Evaluating athletes for cardiovascular disease - Challenging cases explained by the experts
  • Speaker : D Corrado (Padova,IT), H Heidbuchel (Antwerp,BE), L Mont (Barcelona,ES)

Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines.

Congress : ESC Congress 2016

  • Session : Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Daiichi Sankyo Europe GmbH

Panel discussion - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Congress : ESC Congress 2016

  • Session : Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications
  • Speaker : J Weitz (Hamilton,CA), G Y H Lip (Birmingham,GB), R P Giugliano (Boston,US), A Goette (Paderborn,DE), H Heidbuchel (Antwerp,BE)
  • Sponsored by Daiichi Sankyo Europe GmbH

Summary and Q&A - Cardioversion of atrial fibrillation anno domini MMXVI.

Congress : ESC Congress 2016

  • Session : Cardioversion of atrial fibrillation anno domini MMXVI
  • Speaker : G Boriani (Castenaso (Bo),IT), H Heidbuchel (Antwerp,BE)
  • Sponsored by Cardiome

Athlete with atrial fibrillation.

Congress : ESC Congress 2015

  • Session : Management of atrial fibrillation in specific conditions
  • Speaker : H Heidbuchel (Antwerp,BE)

Factors to consider when choosing an oral anticoagulant.

Congress : ESC Congress 2015

  • Session : A royal progression of NOACs
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by theheart.org / Medscape Education

New insights from cardiac MR during uninterrupted exercise.

Congress : EHRA 2015

  • Session : Opportunities to prevent sudden death in sports
  • Speaker : H Heidbuchel (Antwerp,BE)

Panel Discussion: non-vitamin K antagonist oral anticoagulants in atrial fibrillation - Translating trial data into clinical practice.

Congress : ESC Congress 2015

  • Session : Non-vitamin K antagonist oral anticoagulants in atrial fibrillation - Translating trial data into clinical practice
  • Speaker : A J Camm (London,GB), J Weitz (Hamilton,CA), H Heidbuchel (Antwerp,BE), R P Giugliano (Boston,US), P Kirchhof (Birmingham,GB)
  • Sponsored by Daiichi Sankyo

Practical considerations for treatment of atrial fibrillation patients with non-vitamin K antagonist oral anticoagulants.

Congress : ESC Congress 2015

  • Session : Non-vitamin K antagonist oral anticoagulants in atrial fibrillation - Translating trial data into clinical practice
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Daiichi Sankyo

An asymptomatic cyclist with ventricular extrasystoles: reassurance or aggressive evaluation?

Congress : ESC Congress 2014

  • Session : Arrhythmia dilemmas in athletes
  • Speaker : H Heidbuchel (Antwerp,BE)

Application of updated ESC practical guide to avoid harm with novel antocoagulants.

Congress : ESC Congress 2014

  • Session : Hippocratic wisdom: how to use the NOACs and do no harm
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Medscape / theheart.org

Introduction - Hippocratic wisdom: how to use the NOACs and do no harm.

Congress : ESC Congress 2014

  • Session : Hippocratic wisdom: how to use the NOACs and do no harm
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Medscape / theheart.org

Q&A and closing remarks - Hippocratic wisdom: how to use the NOACs and do no harm.

Congress : ESC Congress 2014

  • Session : Hippocratic wisdom: how to use the NOACs and do no harm
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Medscape / theheart.org

Should athletes with implantable cardioverter-defibrillator be allowed to compete? CONTRA.

Congress : ESC Congress 2014

  • Session : Comparison of different criteria for evaluation and management of athletes with certain cardiovascular abnormalities in the US and EU
  • Speaker : H Heidbuchel (Antwerp,BE)

Should athletes with implantable cardioverter-defibrillator be allowed to compete? REBUTTAL CONTRA.

Congress : ESC Congress 2014

  • Session : Comparison of different criteria for evaluation and management of athletes with certain cardiovascular abnormalities in the US and EU
  • Speaker : H Heidbuchel (Antwerp,BE)

What changed in the latest ESC Guidelines for AF, and why?

Congress : ESC Congress 2014

  • Session : Cardioversion in Europe - New trends and treatments
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Cardiome International AG

What is new in stroke prevention in atrial fibrillation?

Congress : ESC Congress 2014

  • Session : Stroke prevention, management of ventricular tachyarrhythmia, devices for heart failure and lead technology - Major breakthroughs in 2013 / messages from EHRA
  • Speaker : H Heidbuchel (Antwerp,BE)

When is exercise harmful? - An athlete with complex ventricular arrhythmias and an abnormal right ventricle.

Congress : ESC Congress 2014

  • Session : When is exercise harmful?
  • Speaker : H Heidbuchel (Antwerp,BE)

Contra.

Congress : ESC Congress 2013

  • Session : Implantable cardioverter-defibrillator patients without shocks should be allowed to participate in sports.
  • Speaker : H Heidbuchel (Antwerp,BE)

Contra.

Congress : ESC Congress 2013

  • Session : Implantable cardioverter-defibrillator patients without shocks should be allowed to participate in sports.
  • Speaker : H Heidbuchel (Antwerp,BE)

It's an endurance training induced disease. The cardiologist's view.

Congress : ESC Congress 2013

  • Session : Sudden death in athletes
  • Speaker : H Heidbuchel (Antwerp,BE)

Practical use of novel oral anticoagulants: the European Heart Rhythm Association guide.

Congress : ESC Congress 2013

  • Session : Novel oral anticoagulants and the cardiologist - Taking pivotal trial evidence into real-world practice
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bayer HealthCare

The use of novel oral anticoagulants in clinical practice.

Congress : ESC Congress 2013

  • Session : The changing landscape in oral anticoagulation - The last pieces of the puzzle
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Daiichi Sankyo Europe

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are